Asuka Ashikari

Dr. Asuka Ashikari

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in International Urology and Nephrology
Verified
Journal Article
Open access
PDF file
MMMinoru Miyazato
Minoru Miyazato
AAAsuka Ashikari
Asuka Ashikari
KNKoshi Nakamura
Koshi Nakamura
TNTakehiro Nakamura
Takehiro Nakamura
KYKiyoto Yamashiro
Kiyoto Yamashiro
MMMasayuki Matsushita
Masayuki Matsushita
Purpose: To evaluate the effect of a mobile digital intervention on voiding patterns, we performed 24-h voided volume monitoring in individuals with metabolic disorders. Methods: Participants with metabolic disorders were grouped into either the intervention group (n = 17), who had access to a smartphone app (CARADA), or the non-intervention group (n = 11), who did not. Urine monitoring was conducted for 24 h using a novel digital self-health monitoring system for urine excretion (s-HMSU). Body weight, abdominal circumference, blood pressure, and biomarkers were measured. Results: Physical findings and blood test results at baseline and 6 months indicated no significant between-group differences. Night-time frequency did not change between baseline and 6 months in the intervention group but significantly worsened at 6 months in the non-intervention group, as compared to baseline (1.0 ± 0.7 vs. 1.5 ± 0.5, p < 0.05). The change in night-time frequency over 6 months did not differ between the intervention and non-intervention groups. Furthermore, the change in hours of undisturbed sleep over 6 months did not differ between the two groups. However, compared with baseline, nocturnal polyuria index tended to worsen at 6 months in the non-intervention group. Conclusion: Our study results suggest that mobile digital intervention might be useful for behavioral therapy to improve night-time frequency and urine production and that s-HMSU might be beneficial for confirming the prevention of progress in individuals with metabolic disorders, which can aid in modifying lifestyle.

1 January 2020 in Folia Pharmacologica Japonica
Verified
Journal Article
Open access
PDF file
MMMinoru Miyazato
Minoru Miyazato
AAAsuka Ashikari
Asuka Ashikari
腹圧性尿失禁(SUI)は,中年女性にみられる一般的疾患で,生活の質を著しく損なう.一方で,臨床的に,あまり有効な薬剤はない.妊娠,出産に伴う女性特有の成因に起因し,尿道過可動と内因性括約筋不全の二つに大別される.腹圧尿失禁の病態,創薬開発にあたって,直接的,間接的陰部神経損傷モデルが使用されている.私達は以前,脳梗塞ラットも尿禁制反射が減弱していることを報告した.SUI評価法として,リークポイント圧測定や尿道マイクロチップ法があり,私たちは後者にくしゃみ刺激を利用する独自の評価方法を確立した.実際,中枢にはSUIの標的が数多く存在することが明らかとなってきている.特に,ノルエピネフリン,セロトニン(5-HT)が標的で,陰部神経核(オヌフ核)周囲に存在するα1受容体,5-HT2C,5-HT7が尿禁制反射を増強,α2,5-HT1Aが減弱することが明らかとなっている.さらに,脊髄オピオイドμ受容体が尿禁制反射を増強することを,弱オピオイドであるトラマドールを用いて報告した.このように,脊髄にはSUIの新たな創薬開発の標的となる受容体が数多く存在する.

23 May 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
AAAsuka Ashikari
Asuka Ashikari
MMMinoru Miyazato
Minoru Miyazato
KNKoshi Nakamura
Koshi Nakamura
KYKiyoto Yamashiro
Kiyoto Yamashiro
TNTakehiro Nakamura
Takehiro Nakamura
MMMasayuki Matsushita
Masayuki Matsushita
(1) Background: Evidence has accumulated regarding the etiology of lower urinary tract symptoms associated with obesity and metabolic syndrome. Therefore, the present study aimed to identify which subjectively and objectively measured voiding parameters were associated with obesity in a community-based population. (2) Methods: Voiding parameters on a self-administered questionnaire and a digital self-health monitoring system for urine excretion (s-HMSU) were compared between participants with and without obesity, defined as a body mass index ≥ 25 kg/m2 (n = 30 and 29, respectively), from a community in Okinawa, Japan. Logistic regression analysis was employed to calculate the odds ratios of abnormalities in voiding parameters for the obese group, with the non-obese group serving as a reference. (3) Results: The obese group had odds ratios of 5.17 (95% confidence interval: 1.33–20.0) for shortened hours of undisturbed sleep (<302 min) by s-HMSU and 7.65 (1.88–31.1) for nighttime urinary frequency by a questionnaire after adjusting for age and sex. In addition, the obese group had an adjusted odds ratio of 2.27 (0.76–6.78) for decreased maximum bladder capacity (<212 mL) by s-HMSU. (4) Conclusion: the results of the present study suggest that nocturia and shortened hours of undisturbed sleep are signs of obesity.

14 September 2022 in Neurourology and Urodynamics
Verified
Journal Article
Closed access
SNSatoko Nagamine
Satoko Nagamine
TKTadanobu Chuyo Kamijo
Tadanobu Chuyo Kamijo
AAAsuka Ashikari
Asuka Ashikari
MMMinoru Miyazato
Minoru Miyazato

1 May 2012 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
PDF file
AYA. Yorozu
A. Yorozu
KTK. Toya
K. Toya
KYK. Yoshida
K. Yoshida
NKN. Koike
N. Koike
ATA. Takahashi
A. Takahashi
AAAsuka Ashikari
Asuka Ashikari

1 May 2012 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
PDF file
AYA. Yorozu
A. Yorozu
KTK. Toya
K. Toya
SSS. Saito
S. Saito
TNT. Nishiyama
T. Nishiyama
KYK. Yoshida
K. Yoshida
AAAsuka Ashikari
Asuka Ashikari